ACE2 and infection: Our data show that in those who were infected before vaccination, those who recovered from the infection prior to vaccination with either the Moderna or AZD1222, there was no difference in the ACE2 blocking antibodies in infected individuals compared to those who were not previously infected, whereas for Sinopharm and Sputnik the ACE2 blocking antibodies were significantly higher in those who were previously infected.